泮托拉唑、阿莫西林联合阿奇霉素或克拉霉素用于根除十二指肠溃疡患者的幽门螺杆菌

Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer.

作者信息

Vcev A, Stimac D, Ivandić A, Vceva A, Takac B, Pezerović D

机构信息

Internal Clinic, Clinical Hospital Osijek, Croatia.

出版信息

Aliment Pharmacol Ther. 2000 Jan;14(1):69-72. doi: 10.1046/j.1365-2036.2000.00662.x.

Abstract

BACKGROUND

Studies have shown that 1-week triple therapy consisting of a proton pump inhibitor, amoxycillin and clarithromycin may cure Helicobacter pylori infection in the majority of patients.

AIM

To establish whether pantoprazole plus amoxycillin in association with either azithromycin or clarithromycin is useful in curing H. pylori infection in patients with a duodenal ulcer.

METHODS

One hundred and ten patients with active duodenal ulcers and H. pylori infection were treated with pantoprazole (days 1-7, 40 mg b.d.; days 8-28 40 mg o.d.) plus amoxycillin 1 g b.d. for the first 7 days. Patients were randomly assigned to receive either azithromycin 500 mg o.d. for the first 6 days (PAAz group; n=55) or clarithromycin 500 mg b.d. for the first 7 days of treatment (PAC group; n=55). H. pylori status was determined by urease test and histology before the treatment, and again 4 weeks after cessation of any medication.

RESULTS

One hundred and three patients completed the study. H. pylori infection was eradicated in 78% (39/50) of patients in the PAAz group (ITT analysis: 71%, 95% CI: 61-83%) vs. 81% (43/53) of patients in the PAC group (ITT analysis: 78%, 95% CI: 69-90%) (N.S.). All ulcers had healed.

CONCLUSION

Our study shows that 1-week triple therapy with pantoprazole, amoxycillin and either azithromycin or clarithromycin is not satisfactory (<80% ITT H. pylori eradication rate).

摘要

背景

研究表明,由质子泵抑制剂、阿莫西林和克拉霉素组成的1周三联疗法可治愈大多数患者的幽门螺杆菌感染。

目的

确定泮托拉唑加阿莫西林联合阿奇霉素或克拉霉素是否有助于治愈十二指肠溃疡患者的幽门螺杆菌感染。

方法

110例活动性十二指肠溃疡合并幽门螺杆菌感染的患者接受泮托拉唑治疗(第1 - 7天,每日2次,每次40mg;第8 - 28天,每日1次,每次40mg)加阿莫西林,前7天每日2次,每次1g。患者被随机分配接受阿奇霉素治疗,前6天每日1次,每次500mg(PAAz组;n = 55)或克拉霉素治疗,治疗的前7天每日2次,每次500mg(PAC组;n = 55)。治疗前通过尿素酶试验和组织学确定幽门螺杆菌状态,在停止任何药物治疗4周后再次确定。

结果

103例患者完成了研究。PAAz组78%(39/50)的患者幽门螺杆菌感染得到根除(意向性分析:71%,95%CI:61 - 83%),而PAC组为81%(43/53)(意向性分析:78%,95%CI:69 - 90%)(无统计学差异)。所有溃疡均已愈合。

结论

我们的研究表明,泮托拉唑、阿莫西林和阿奇霉素或克拉霉素的1周三联疗法并不理想(意向性分析中幽门螺杆菌根除率<80%)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索